<code id='53266F32AB'></code><style id='53266F32AB'></style>
    • <acronym id='53266F32AB'></acronym>
      <center id='53266F32AB'><center id='53266F32AB'><tfoot id='53266F32AB'></tfoot></center><abbr id='53266F32AB'><dir id='53266F32AB'><tfoot id='53266F32AB'></tfoot><noframes id='53266F32AB'>

    • <optgroup id='53266F32AB'><strike id='53266F32AB'><sup id='53266F32AB'></sup></strike><code id='53266F32AB'></code></optgroup>
        1. <b id='53266F32AB'><label id='53266F32AB'><select id='53266F32AB'><dt id='53266F32AB'><span id='53266F32AB'></span></dt></select></label></b><u id='53266F32AB'></u>
          <i id='53266F32AB'><strike id='53266F32AB'><tt id='53266F32AB'><pre id='53266F32AB'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:8474
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Pfizer highlights cancer drugs it thinks could reignite investor interest
          Pfizer highlights cancer drugs it thinks could reignite investor interest

          AscreenattheNewYorkStockExchangelastNovember.MichaelM.Santiago/GettyImagesPfizerspentmorethanfourhou

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          What's changing in Medicare's open enrollment this year?

          AdobeIt’sthemiddleofOctober—thetimeofyearthat’sfilledwithpumpkinspicelattes,jumbo-sizedbagsofHallowe